Product Description
Since lastmany years SaintroyLifescienceis leading manufacture, export andsupplier ofLatanoprost and Timolol Maleate Eye Drop from Surat, Gujarat, India. Latanoprost and Timolol Maleate Eye Drop used in glaucoma,consisting of latanoprost (increase uveoscleral outflow of aqueous humor.
Tags: Latanoprost and Timolol Maleate Eye Drop manufacturer, Latanoprost and Timolol MaleateEye Drop exporter, Latanoprost andTimolol Maleate Eye Drop supplier, and Latanoprostand Timolol Maleate Eye Drop , whogmp approved Latanoprost and Timolol MaleateEye Drop manufacturer and supplier, Latanoprostand Timolol Maleate Eye Drop distributor,Latanoprost and Timolol Maleate Eye Drop shipper, Latanoprost and Timolol Maleate EyeDrop 2.5 ml Latanoprost and TimololMaleate Eye Drop 2.5 mlsupplier, Latanoprostand Timolol Maleate Eye Drop 2.5 ml.
ISO/GMP/cGMP/WHOGMP/NAFDACapproved, PPB Kenya approved/USFDA approved/EUGMP approved/MOH Iran approvedmanufacturingfacility in Gujarat, India.
Registration: Saintroy Lifescienceis interested inregistration of own brand or customer brands in ministryof health ofclients country and we also provide the products samples, COA, COPP, ACTD or CTDossier, DMF, Manufacturing license, Free sales certificate and other requireddocuments.
Export Country:Saintroy LifescienceLatanoprost andTimolol Maleate Eye Drop export to USA,Canada, Germany, Europe, France, Ghana, Nigeria, Kenya, Senegal, Sudan,UAE, Kuwait,Dubai, Cameroon, Lebanon, Peru, Chile, Somalia, Philippines, Myanmar, Maldives,Thailand, Singapore, Malaysia, Hong Kong, China, Zimbabwe, Togo, Burkina Faso,Niger,Guinea Bissau, Congo, Democratic of republic, Ivory Costa, Oman,Guatemala, Nicaragua, Salvador, Qatar, Costa Rica, Panama, Cuba, Colombia,Bolivia, Argentine, Algeria, Guyana, Morocco, Jordan, Bahrain, Iran, Egypt,Kyrgyzstan, Uzbekistan, Kazakhstan.
Dual-Action Eye SolutionCombining Latanoprost and Timolol Maleate, this eye drop targets eye pressure through two distinct mechanisms, promoting better management of glaucoma and related conditions. The formulation is ideal for adults and is suitable for use across age groups when advised by a doctor.
Trusted Distribution Across IndiaAvailable through manufacturers, suppliers, traders, dealers, and exporters, this eye drop is distributed widely in India. Each unit undergoes strict quality control to ensure reliability and therapeutic effectiveness for both local and international clients.
FAQ's of Latanoprost and Timolol Maleate Eye Drop:
Q: How should Latanoprost and Timolol Maleate Eye Drop be administered?
A: The eye drops should be used exactly as directed by your doctor. Typically, a prescribed number of drops are placed in the affected eye(s) once daily, but do not self-medicate or change the dosage without consulting a healthcare professional.
Q: What conditions are treated with Latanoprost and Timolol Maleate Eye Drop?
A: This medication is mainly used to lower elevated intraocular pressure in individuals with glaucoma or ocular hypertension, helping to reduce the risk of vision loss due to optic nerve damage.
Q: When is the best time to use these eye drops?
A: Your doctor will provide specific instructions on timing, but it is usually recommended to use the eye drops at the same time each day to maintain consistent therapeutic levels and efficacy.
Q: Where is this medication available in India?
A: Latanoprost and Timolol Maleate Eye Drop is distributed throughout India by authorized dealers, distributors, exporters, manufacturers, suppliers, and wholesalers. It can be obtained at licensed pharmacies with a valid prescription.
Q: What is the process for using the eye drops safely?
A: To ensure safe usage, always wash your hands before use, avoid touching the dropper tip, and strictly follow your doctor's dosage instructions. Do not allow the dropper to contact any surface and replace the cap promptly after use.
Q: What are the main benefits of using this dual-combination eye drop?
A: By combining Latanoprost and Timolol, this medication provides a synergistic effect to more effectively lower eye pressure, thus offering better control over glaucoma progression for a broad patient demographic.